EndoC-bH3 — PKBSM0561GQKP

released
{
    "@context": "/terms/",
    "@id": "/human-beta-cell-line/PKBSM0561GQKP/",
    "@type": [
        "HumanBetaCellLines",
        "Biosample",
        "Sample",
        "Item"
    ],
    "accession": "PKBSM0561GQKP",
    "age": "unknown",
    "aliases": [
        "pankbase-consortium:EndoC-bH3_treated_4-hydroxytamoxifen3wk_GSE207816"
    ],
    "audit": {
        "INTERNAL_ACTION": [
            {
                "category": "mismatched status",
                "detail": "Released human beta cell lines [PKBSM0561GQKP](/human-beta-cell-line/PKBSM0561GQKP/) has in progress subobject sample term [CVCL_IS72](/sample-terms/CVCL_IS72/).",
                "level": 30,
                "level_name": "INTERNAL_ACTION",
                "name": "audit_item_status",
                "path": "/human-beta-cell-line/PKBSM0561GQKP/"
            }
        ],
        "WARNING": [
            {
                "category": "incorrect classifications format",
                "detail": "Human beta cell line [PKBSM0561GQKP](/human-beta-cell-line/PKBSM0561GQKP/) has `classifications` ['human beta cell line'] but should be [\"cell line\"]. Human beta cell lines are expected to have classifications as an array.",
                "level": 40,
                "level_name": "WARNING",
                "name": "audit_classifications_format_check",
                "path": "/human-beta-cell-line/PKBSM0561GQKP/"
            }
        ]
    },
    "award": {
        "@id": "/awards/U24DK138512-DK138515/",
        "component": "data coordination"
    },
    "classifications": [
        "human beta cell line"
    ],
    "coating_condition": "ECM, fibronectin",
    "creation_timestamp": "2025-10-21T21:46:35.747579+00:00",
    "description": "EndoC-bH3 cells treated with 4-hydroxy tamoxifen for three weeks from GSE207816",
    "donors": [
        {
            "@id": "/human-donors/PKBDO8293TLPA/",
            "accession": "PKBDO8293TLPA",
            "age": 0,
            "summary": "PKBDO8293TLPA",
            "taxa": "Homo sapiens"
        }
    ],
    "excision_status": "excised",
    "file_sets": [
        {
            "@id": "/analysis-sets/PKBDS6778XLCV/",
            "accession": "PKBDS6778XLCV",
            "aliases": [
                "pankbase-consortium:EndoC-bH3_treated_4-hydroxytamoxifen3wk_GSE207816_AnalysisSet"
            ],
            "lab": {
                "title": "Pankbase Consortium, PanKbase"
            },
            "status": "released",
            "summary": "intermediate analysis of RNA-seq data"
        },
        {
            "@id": "/measurement-sets/PKBDS0486ONFQ/",
            "accession": "PKBDS0486ONFQ",
            "aliases": [
                "pankbase-consortium:EndoC-bH3_treated_4-hydroxytamoxifen3wk_GSE207816_MeasurementSet"
            ],
            "assay_term": {
                "term_name": "bulk RNA-seq assay"
            },
            "lab": {
                "title": "Pankbase Consortium, PanKbase"
            },
            "status": "released",
            "summary": "bulk RNA-seq assay (RNA-seq)"
        }
    ],
    "growth_medium": "DMEM low glucose (1 g/L) supplemented with 2% fatty acid free BSA , 10 mM nicotinamide, 5.5 µg/mL human transferrin, 6.7 ng/mL sodium selenite, 50 µM β-mercaptoethanol, 100 U/mL penicillin and 100 µg/mL streptomycin",
    "institutional_certificates": [],
    "lab": {
        "@id": "/labs/pankbase-consortium/",
        "title": "Pankbase Consortium, PanKbase"
    },
    "multiplexed_in": [],
    "origin_of": [],
    "parts": [],
    "pooled_in": [],
    "publication_identifiers": [
        "PMID:38682582"
    ],
    "release_timestamp": "2025-10-27T19:40:52.477647+00:00",
    "sample_name": "EndoC-bH3",
    "sample_terms": [
        {
            "@id": "/sample-terms/CVCL_IS72/",
            "term_name": "EndoC-bH3"
        }
    ],
    "sorted_fractions": [],
    "status": "released",
    "submitted_by": {
        "@id": "/users/5e3038c4-baa5-4589-b3d8-ad2fe634e826/",
        "title": "Ying Sun"
    },
    "summary": "EndoC-bH3 cell line, treated with 1 mM 4-hydroxy tamoxifen for 21 days",
    "taxa": "Homo sapiens",
    "treatments": [
        {
            "@id": "/treatments/8741ffa1-584b-4e39-8137-f3b67145ec9d/",
            "purpose": "activation",
            "status": "released",
            "summary": "Treatment of 1 mM 4-hydroxy tamoxifen for 21 days",
            "treatment_type": "chemical"
        }
    ],
    "uuid": "f084aa15-7786-4443-ae29-b3180964b313",
    "virtual": false
}